Notify me when Chubb Ltd files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | 3 | $29,898,058 | $0 | $0 | $0 | GRAB, NU, PTCT | 13F-HR | 03 Feb 2023, 12:09 |
| Q3 2022 | 3 | $26,996,000 | $0 | $0 | $0 | GRAB, NU, PTCT | 13F-HR | 04 Nov 2022, 10:02 |
| Q2 2022 | 3 | $24,794,000 | $0 | -$285,000 | -$285,000 | GRAB, NU, PTCT | 13F-HR | 05 Aug 2022, 09:50 |
| Q1 2022 | 4 | $40,165,000 | +$17,655,000 | $0 | +$17,655,000 | GRAB, NU, PTCT, NEWT | 13F-HR | 06 May 2022, 08:23 |
| Q4 2021 | 2 | $45,560,000 | +$45,234,000 | $0 | +$45,234,000 | GRAB, PTCT | 13F-HR | 04 Feb 2022, 09:44 |
| Q3 2021 | 1 | $304,000 | $0 | -$27,885,000 | -$27,885,000 | PTCT | 13F-HR | 08 Nov 2021, 15:16 |
| Q2 2021 | 3 | $28,231,000 | +$238,000 | -$6,004,839 | -$5,766,839 | DCT, PTCT, NEWT | 13F-HR | 05 Aug 2021, 14:29 |
| Q1 2021 | 2 | $35,299,000 | $0 | -$74,456,878 | -$74,456,878 | DCT, PTCT | 13F-HR | 05 May 2021, 10:02 |
| Q4 2020 | 3 | $106,657,000 | +$102,004,850 | -$446,000 | +$101,558,850 | DCT, SNY, PTCT | 13F-HR | 05 Feb 2021, 16:36 |
| Q3 2020 | 3 | $5,116,000 | $0 | -$22,711,650 | -$22,711,650 | SNY, PHR, PTCT | 13F-HR | 30 Oct 2020, 13:41 |
| Q2 2020 | 4 | $28,147,000 | +$4,439,248 | $0 | +$4,439,248 | SNY, PHR, PTCT, NEWT | 13F-HR | 11 Aug 2020, 11:03 |
| Q1 2020 | 3 | $20,271,000 | +$3,410 | $0 | +$3,410 | SNY, PTCT, NEWT | 13F-HR | 30 Apr 2020, 09:33 |
| Q4 2019 | 3 | $23,375,000 | +$4,601 | $0 | +$4,601 | SNY, PTCT, NEWT | 13F-HR | 14 Feb 2020, 11:00 |
| Q3 2019 | 3 | $21,512,000 | +$3,500 | $0 | +$3,500 | SNY, NEWT, PTCT | 13F-HR | 06 Nov 2019, 11:58 |
| Q2 2019 | 3 | $20,230,000 | $0 | -$128,362,496 | -$128,362,496 | SNY, NEWT, PTCT | 13F-HR | 07 Aug 2019, 10:25 |
| Q1 2019 | 12 | $148,927,000 | +$10,635 | -$2,000 | +$8,635 | MRK, SNY, BP, PFE, GSK | 13F-HR | 30 Apr 2019, 11:40 |
| Q4 2018 | 13 | $137,925,000 | +$3,013 | -$742,000 | -$738,987 | MRK, SNY, PFE, TTE, GSK | 13F-HR | 08 Feb 2019, 10:07 |
| Q3 2018 | 14 | $150,842,000 | +$3,272 | -$95,878,881 | -$95,875,609 | MRK, SNY, TTE, BP, PFE | 13F-HR | 31 Oct 2018, 11:51 |
| Q2 2018 | 21 | $237,950,000 | +$1,422,263 | $0 | +$1,422,263 | MS, JPM, ADM, BP, MRK | 13F-HR | 27 Jul 2018, 10:17 |
| Q1 2018 | 20 | $229,965,000 | +$224,022 | $0 | +$224,022 | MS, JPM, ADM, SNY, AZN | 13F-HR | 01 May 2018, 14:25 |
| Q4 2017 | 19 | $229,757,000 | +$9,719 | -$934,000 | -$924,281 | MS, JPM, SNY, ADM, AZN | 13F-HR | 26 Jan 2018, 14:08 |
| Q3 2017 | 21 | $229,324,000 | $0 | -$12,087,450 | -$12,087,450 | MS, SNY, MRK, ADM, JPM | 13F-HR | 27 Oct 2017, 10:18 |
| Q2 2017 | 21 | $235,387,000 | +$28,742 | $0 | +$28,742 | MS, SNY, MRK, ADM, JPM | 13F-HR | 28 Jul 2017, 10:28 |
| Q1 2017 | 22 | $231,601,000 | +$137 | -$2,084,625 | -$2,084,488 | MS, ADM, SNY, MRK, JPM | 13F-HR | 04 May 2017, 08:30 |
| Q4 2016 | 25 | $227,792,000 | +$1,019,037 | -$77,474 | +$941,563 | MS, ADM, SNY, MRK, JPM | 13F-HR | 14 Feb 2017, 14:48 |
| Q3 2016 | 24 | $220,516,000 | +$1,807,958 | -$22,088,930 | -$20,280,972 | ADM, MRK, GSK, SNY, AZN | 13F-HR | 14 Nov 2016, 17:49 |
| Q2 2016 | 27 | $231,340,000 | +$2,753,157 | -$148,085,000 | -$145,331,843 | ADM, SNY, GSK, MRK, AZN | 13F-HR | 12 Aug 2016, 11:28 |
| Q1 2016 | 38 | $366,975,000 | $0 | $0 | $0 | SNY, BAC, C, AAL, ADM | 13F-HR | 13 May 2016, 10:35 |